Blockade of T lymphocyte down-regulation associated with CTLA-4

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Monoclonal antibody or fragment thereof

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

4241331, 4241411, 4241431, 4241521, 4241541, 4241301, 4241351, 424810, 514 2, 514 12, 514885, 5303871, 5303873, 5303881, 53038822, 5303887, C07K 1628, C07K 14725, A61K 39395

Patent

active

058110976

ABSTRACT:
T cell activation in response to antigen is increased by the administration of binding agents that block CTLA-4 signaling. When CTLA-4 signaling is thus blocked, the T cell response to antigen is released from inhibition. Such an enhanced response is useful for the treatment of tumors, chronic viral infections, and as an adjuvant during immunization.

REFERENCES:
patent: 556763 (1896-09-01), Ochoa et al.
patent: 5434131 (1995-07-01), Linsley et al.
Damle et al., "Costimulation of T Lymphocytes with Integrin Ligands Intercellular Adhesion Molecule-1 or Vascular Cell Adhesion Molecule-1 Induces Functional Expression of CTLA-4, A Second Receptor for B7," Journal of Immunology 152:2686-2697 (1994).
Lin et al., "Long-Term Acceptance of Major Histocompatibility Complex Mismatched Cardiac Allografts Induced by CTLA4lg Plus Donor-Specific Transfusion," J. Exp. Med. 178:1801-1806 (1993).
Turka et al., "T-Cell Activation by the CD28 Ligand B7 is Required for Cardiac Allograft Rejection in vivo," Proc. Natl. Acad. Sci. USA 89:11102-11105 (1992).
Linsley, P.S. and J.A. Ledbetter, "The Role of the CD28 Receptor During T Cell Responses to Antigen," Ann. Rev. Immunol. 11:191-212 (1993).
Wu et al., "CTLA-4-B7 Interaction is Sufficient to Costimulate T Cell Clonal Expansion," J. Exp. Med. 185(7):1327-1335 (1997).
Linsley, P.S., "Distinct Roles for CD28 and Cytotoxic Lymphocyte-Associated Molecule-4 Receptors During T Cell Activation," J. Exp. Med., 182:289-292 (1995).
Walumas, TL et al Immunity 1:403-413, Aug. 1994.
Kearney ER et al J. Immunol 155:1032-1036 Aug. 1, 1995.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Blockade of T lymphocyte down-regulation associated with CTLA-4 does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Blockade of T lymphocyte down-regulation associated with CTLA-4 , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Blockade of T lymphocyte down-regulation associated with CTLA-4 will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1620108

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.